A team at the University of Cambridge has developed a broad-spectrum bird flu vaccine using an AI-guided design technique that outperformed current stockpiled jabs in animal trials. By providing protection against a wide range of viral variants, this approach offers a new way to prepare for potential human outbreaks and could be adapted to target other infectious diseases.

About the AI positivity score